152 related articles for article (PubMed ID: 7942286)
1. Targeted and non-targeted actions of anti-cancer drugs.
Weber G; Prajda N
Adv Enzyme Regul; 1994; 34():71-89. PubMed ID: 7942286
[TBL] [Abstract][Full Text] [Related]
2. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
[TBL] [Abstract][Full Text] [Related]
3. Regulation of de novo and salvage pathways in chemotherapy.
Weber G; Nagai M; Natsumeda Y; Ichikawa S; Nakamura H; Eble JN; Jayaram HN; Zhen WN; Paulik E; Hoffman R
Adv Enzyme Regul; 1991; 31():45-67. PubMed ID: 1877399
[TBL] [Abstract][Full Text] [Related]
4. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
[TBL] [Abstract][Full Text] [Related]
5. Salvage capacity of hepatoma 3924A and action of dipyridamole.
Weber G; Lui MS; Natsumeda Y; Faderan MA
Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate decreases thymidine kinase activity.
Abonyi M; Prajda N; Hata Y; Nakamura H; Weber G
Biochem Biophys Res Commun; 1992 Aug; 187(1):522-8. PubMed ID: 1520343
[TBL] [Abstract][Full Text] [Related]
7. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
[TBL] [Abstract][Full Text] [Related]
8. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
Natsumeda Y; Ikegami T; Olah E; Weber G
Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
[TBL] [Abstract][Full Text] [Related]
9. Antimetabolites reduce the activities of enzymes with short half-lives in addition to inhibiting their specific targets.
Weber G; Prajda N; Singhal RL
Adv Exp Med Biol; 1994; 370():145-50. PubMed ID: 7660878
[No Abstract] [Full Text] [Related]
10. Tiazofurin: molecular and clinical action.
Weber G; Prajda N; Abonyi M; Look KY; Tricot G
Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
[TBL] [Abstract][Full Text] [Related]
11. Role of differentiation induction in action of purine antimetabolites.
Weber G; Hata Y; Prajda N
Pharm World Sci; 1994 Apr; 16(2):77-83. PubMed ID: 8032345
[TBL] [Abstract][Full Text] [Related]
12. Regulation of GTP biosynthesis.
Weber G; Nakamura H; Natsumeda Y; Szekeres T; Nagai M
Adv Enzyme Regul; 1992; 32():57-69. PubMed ID: 1353938
[TBL] [Abstract][Full Text] [Related]
13. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
Kensler TW; Jayaram HN; Cooney DA
Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804
[TBL] [Abstract][Full Text] [Related]
14. Salvage pathways as targets of chemotherapy.
Weber G; Jayaram HN; Pillwein K; Natsumeda Y; Reardon MA; Zhen YS
Adv Enzyme Regul; 1987; 26():335-52. PubMed ID: 3673709
[TBL] [Abstract][Full Text] [Related]
15. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
16. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
[TBL] [Abstract][Full Text] [Related]
17. Targets and markers of selective action of tiazofurin.
Weber G; Natsumeda Y; Pillwein K
Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
[TBL] [Abstract][Full Text] [Related]
18. Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum.
Reyes P; Rathod PK; Sanchez DJ; Mrema JE; Rieckmann KH; Heidrich HG
Mol Biochem Parasitol; 1982 May; 5(5):275-90. PubMed ID: 6285190
[TBL] [Abstract][Full Text] [Related]
19. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
Weber G; Nagai M; Prajda N; Nakamura H; Szekeres T; Olah E
Cancer Commun; 1991 Apr; 3(4):127-32. PubMed ID: 2025497
[TBL] [Abstract][Full Text] [Related]
20. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
Zhen YS; Taniki T; Weber G
Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]